News
-
-
-
-
-
-
PRESS RELEASE
Evotec announces significant progress in strategic protein degradation collaboration with Bristol Myers Squibb
Evotec SE announces significant progress in strategic protein degradation collaboration with Bristol Myers Squibb, expanding pipeline of molecular glue degraders for unmet medical needs. Performance-based payments totaling US$75 m -
-
-
-